日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer

3D功能基因组学筛选发现CREBBP是侵袭性三阴性乳腺癌的可靶向驱动基因

Barrie Peck,Philip Bland #,Ioanna Mavrommati #,Gareth Muirhead #,Hannah Cottom,Patty T Wai,Sarah L Maguire,Holly E Barker,Eamonn Morrison,Divya Kriplani,Lu Yu,Amy Gibson,Giulia Falgari,Keith Brennan,Gillian Farnie,Richard Buus,Rebecca Marlow,Daniela Novo,Eleanor Knight,Naomi Guppy,Daniela Kolarevic,Snezana Susnjar,Natasa Medic Milijic,Kalnisha Naidoo,Patrycja Gazinska,Ioannis Roxanis,Sunil Pancholi,Lesley-Ann Martin,Erle M Holgersen,Maggie C U Cheang,Farzana Noor,Sophie Postel-Vinay  ,Gerard Quinn,Simon McDade,Lukas Krasny,Paul Huang,Frances Daley,Fredrik Wallberg,Jyoti S Choudhary,Syed Haider,Andrew N Tutt,Rachael Natrajan

Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer

原发性三阴性乳腺癌中的同源重组DNA修复缺陷和PARP抑制活性

Neha Chopra, Holly Tovey, Alex Pearson, Ros Cutts, Christy Toms, Paula Proszek, Michael Hubank, Mitch Dowsett, Andrew Dodson, Frances Daley, Divya Kriplani, Heidi Gevensleben, Helen Ruth Davies, Andrea Degasperi, Rebecca Roylance, Stephen Chan, Andrew Tutt, Anthony Skene, Abigail Evans, Judith M Bli

Optimised ARID1A immunohistochemistry is an accurate predictor of ARID1A mutational status in gynaecological cancers

优化的 ARID1A 免疫组织化学可以准确预测妇科癌症中 ARID1A 突变状态

Saira Khalique, Kalnisha Naidoo, Ayoma D Attygalle, Divya Kriplani, Frances Daley, Anne Lowe, James Campbell, Thomas Jones, Michael Hubank, Kerry Fenwick, Nicholas Matthews, Alistair G Rust, Christopher J Lord, Susana Banerjee, Rachael Natrajan

SOX11 promotes invasive growth and ductal carcinoma in situ progression

SOX11 促进浸润性生长和导管原位癌进展

Erik Oliemuller, Naoko Kogata, Philip Bland, Divya Kriplani, Frances Daley, Syed Haider, Vandna Shah, Elinor J Sawyer, Beatrice A Howard

Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer

PARP 抑制剂 BMN-673 治疗卵巢透明细胞癌的临床前评估

Paul M Wilkerson, Konstantin J Dedes, Eleftherios Pierre Samartzis, Ioannis Dedes, Maryou B Lambros, Rachael Natrajan, Arnaud Gauthier, Salvatore Piscuoglio, Chantal Töpfer, Vesna Vukovic, Frances Daley, Britta Weigelt, Jorge S Reis-Filho

Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases

血管选择介导肝转移瘤对抗血管生成治疗的抵抗

Sophia Frentzas #, Eve Simoneau #, Victoria L Bridgeman #, Peter B Vermeulen #, Shane Foo, Eleftherios Kostaras, Mark Nathan, Andrew Wotherspoon, Zu-Hua Gao, Yu Shi, Gert Van den Eynden, Frances Daley, Clare Peckitt, Xianming Tan, Ayat Salman, Anthoula Lazaris, Patrycja Gazinska, Tracy J Berg, Zak E

Co-option of Liver Vessels and Not Sprouting Angiogenesis Drives Acquired Sorafenib Resistance in Hepatocellular Carcinoma

肝血管的选择和非新生血管生成导致肝细胞癌获得性索拉非尼耐药

Elizabeth A Kuczynski, Melissa Yin, Avinoam Bar-Zion, Christina R Lee, Henriett Butz, Shan Man, Frances Daley, Peter B Vermeulen, George M Yousef, F Stuart Foster, Andrew R Reynolds, Robert S Kerbel

The relationship between homologous recombination repair and the sensitivity of human epidermis to the size of daily doses over a 5-week course of breast radiotherapy

同源重组修复与人类表皮对乳腺放射治疗 5 周期间每日剂量大小的敏感性之间的关系

Navita Somaiah, John Yarnold, Frances Daley, Ann Pearson, Lone Gothard, Kai Rothkamm, Thomas Helleday